REPLIMUNE GROUP, INC. Other Executive Compensation Disclosures
Every other executive-compensation XBRL fact the company filed (policies, award timing, footnotes, adjustments), newest first. Long text is shortened; the filing has the full text.
- 2026-08-14: Disclosure Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Non Rule10b51Arr Adopted; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
- 2026-08-14: Disclosure Non Rule10b51Arr Terminated; Period 2026-04-01..2026-06-30; Value No.
| Filed | Disclosure | Qualifiers | Period | Value |
|---|---|---|---|---|
| 2026-08-14 10-Q | Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Non Rule10b51Arr Adopted | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-08-14 10-Q | Non Rule10b51Arr Terminated | 2026-04-01..2026-06-30 | No | |
| 2026-07-29 DEF 14A | Insider Trading Policies Proc Adopted | 2025-04-01..2026-03-31 | Yes | |
| 2026-07-29 DEF 14A | Award Timing MNPI Disclosure | 2025-04-01..2026-03-31 | The Compensation Committee reviews and approves individual equity grants for the named executive officers and directors, as well as the total number of shares underlying grants made to all employees. The annual equity grants typically are reviewed and approved at the Compensation Committee’s regular… | |
| 2026-07-29 DEF 14A | Award Timing Method | 2025-04-01..2026-03-31 | The annual equity grants typically are reviewed and approved at the Compensation Committee’s regular meeting during the third quarter of the fiscal year, although sign-on equity awards are generally approved by the Compensation Committee at the time an executive officer commences employment with the… | |
| 2026-07-29 DEF 14A | Award Timing Predetermined | 2025-04-01..2026-03-31 | Yes | |
| 2026-07-29 DEF 14A | Award Timing How MNPI Considered | 2025-04-01..2026-03-31 | We do not grant equity awards in anticipation of the release of material nonpublic information that is likely to result in changes to the price of our common stock, and do not time the public release of such information based on award grant dates. | |
| 2026-07-29 DEF 14A | Award Timing MNPI Considered | 2025-04-01..2026-03-31 | No | |
| 2026-07-29 DEF 14A | MNPI Disclosure Timed For Compensation Val | 2025-04-01..2026-03-31 | No | |
| 2026-07-29 DEF 14A | Pay versus Performance Table | 2025-04-01..2026-03-31 | Pay Versus Performance Table The following table provides the information required for our NEOs for each of the fiscal years ended March 31, 2026, March 31, 2025 and March 31, 2024, along with the financial information required for each fiscal year. As a pre-commercial biotechnology company, we do n… | |
| 2026-07-29 DEF 14A | Named Executive Officers Footnote | 2025-04-01..2026-03-31 | (1) PEO for FY 2025 and 2026: Sushil Patel; PEO for FY 2024: Philip Astley-Sparke (4) Non-PEO NEOs reflect the average Summary Compensation Table total compensation and average Compensation Actually Paid for the following executives by year: • 2024, 2025, and 2026: Ms. Emily Hill and Dr. Konstanti… | |
| 2026-07-29 DEF 14A | Adjustment To PEO Compensation Footnote | 2025-04-01..2026-03-31 | (2) Deductions from, and additions to, total compensation reported in the Summary Compensation Table by year to calculate CAP (in accordance with Item 402(v) of Regulation S-K) include: 2026 2025 2024 Sushil Patel Average Non-CEO NEOs Sushil Patel Average Non-CEO … | |
| 2026-07-29 DEF 14A | Adjustment To Non PEO NEO Compensation Footnote | 2025-04-01..2026-03-31 | (2) Deductions from, and additions to, total compensation reported in the Summary Compensation Table by year to calculate CAP (in accordance with Item 402(v) of Regulation S-K) include: 2026 2025 2024 Sushil Patel Average Non-CEO NEOs Sushil Patel Average Non-CEO … | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | -$4.82M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | -$1.36M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | -$2.63M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | -$842.93K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | -$5.06M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | -$2.40M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | $4.35M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | $1.22M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | $3.70M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | $1.18M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | $2.04M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstd; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | $969.65K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | -$1.51M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | -$527.17K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | $129.32K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | $115.33K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | -$1.62M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrs; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | -$407.52K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | -$247.72K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | -$107.98K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | -$11.04K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | $94.72K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | -$231.77K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | -$104.72K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | -$2.23M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | -$778.74K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | $1.18M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | $551.12K |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | -$4.87M |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: EqtyAwrdsAdjs; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | -$1.94M |
| 2026-07-29 DEF 14A | Compensation Actually Paid Vs Total Shareholder Return | 2025-04-01..2026-03-31 | CAP versus TSR | |
| 2026-07-29 DEF 14A | Compensation Actually Paid Vs Net Income | 2025-04-01..2026-03-31 | CAP versus Net Loss | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: AggtChngPnsnValInSummryCompstnTblForAplblYr; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: SushilPatel | 2025-04-01..2026-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2025-04-01..2026-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2024-04-01..2025-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2024-04-01..2025-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: Peo; Individual: PhilipAstleySparke | 2023-04-01..2024-03-31 | |
| 2026-07-29 DEF 14A | Adjustment To Compensation | AdjToComp: VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYr; ExecutiveCategory: NonPeoNeo | 2023-04-01..2024-03-31 | |
| 2026-06-29 10-K | Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-06-29 10-K | Non Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-06-29 10-K | Non Rule10b51Arr Terminated | 2026-01-01..2026-03-31 | No | |
| 2026-06-29 10-K | Rule10b51Arr Adopted | 2026-01-01..2026-03-31 | No | |
| 2026-06-29 10-K | Insider Trading Policies Proc Adopted | 2025-04-01..2026-03-31 | Yes | |
| 2026-02-03 10-Q | Material Terms Of Trading Arrangement | 2025-10-01..2025-12-31 | Name & Title Date Adopted (1) Aggregate Number of Shares of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement Expiration Date (3) Christopher Sarchi,Chief Commercial Officer 12/15/2025 (2) 18,500 December 11, 2026 Andrew Schwendenman, Chief Accounting Officer 12/16/2025 (2… | |
| 2026-02-03 10-Q | Non Rule10b51Arr Adopted | 2025-10-01..2025-12-31 | No | |
| 2026-02-03 10-Q | Non Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No | |
| 2026-02-03 10-Q | Rule10b51Arr Terminated | 2025-10-01..2025-12-31 | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |